Literature DB >> 10580870

Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function.

D Vordermark1, M Sailer, M Flentje, A Thiede, O Kölbl.   

Abstract

In 22 colostomy-free survivors of curative-intent radiation therapy or chemoradiation for anal carcinoma, measurement of the Gastrointestinal Quality of Life Index (GIQLI) revealed a mean 114 of a maximum 144 points, as compared to 121 in healthy volunteers (n = 150) and 113 in patients with benign anorectal diseases (n = 325). Sixteen patients underwent anorectal manometry to determine anal sphincter length (SL), resting pressure (RP), maximum squeeze pressure (MSP), rectal compliance (RC) and relaxation of the internal anal sphincter (RIAS). SL, RP and MSP were significantly lower in anal carcinoma patients than in healthy volunteers. Complete continence was detected in 56% of patients.

Entities:  

Mesh:

Year:  1999        PMID: 10580870     DOI: 10.1016/s0167-8140(99)00096-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.

Authors:  J G Baek; E C Kim; S K Kim; H Jang
Journal:  Br J Radiol       Date:  2015-09-23       Impact factor: 3.039

Review 2.  Effects of radiation therapy on the structure and function of the pelvic floor muscles of patients with cancer in the pelvic area: a systematic review.

Authors:  Stéphanie Bernard; Marie-Pier Ouellet; Hélène Moffet; Jean-Sébastien Roy; Chantale Dumoulin
Journal:  J Cancer Surviv       Date:  2015-08-28       Impact factor: 4.442

3.  Neoadjuvant radiochemotherapy for patients with locally advanced rectal cancer leads to impairment of the anal sphincter.

Authors:  Joerg Theisen; Werner K-H Kauer; Hjalmar Nekarda; Ludwig Schmid; Hubert J Stein; Joerg-Ruediger Siewert
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

4.  Quality of life outcomes in patients with anal cancer after combined radiochemotherapy.

Authors:  Grit Welzel; Verena Hägele; Frederik Wenz; Sabine Kathrin Mai
Journal:  Strahlenther Onkol       Date:  2011-02-21       Impact factor: 3.621

5.  Quality of life in very elderly radiotherapy patients: a prospective pilot study using the EORTC QLQ-ELD14 module.

Authors:  Anne Kaufmann; Heike Schmidt; Christian Ostheimer; Janine Ullrich; Margarete Landenberger; Dirk Vordermark
Journal:  Support Care Cancer       Date:  2014-12-06       Impact factor: 3.603

6.  Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.

Authors:  Lisa A Kachnic; Kathryn A Winter; Robert J Myerson; Michael D Goodyear; Andre A Abitbol; Oscar E Streeter; Mark E Augspurger; Tracey E Schefter; Alan W Katz; Barbara J Fisher; Lauren E Henke; Samir Narayan; Christopher H Crane
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-14       Impact factor: 8.013

7.  Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients.

Authors:  Alexander P Pietsch; Rainer Fietkau; Günther Klautke; Thomas Foitzik; Ernst Klar
Journal:  Int J Colorectal Dis       Date:  2007-05-12       Impact factor: 2.571

Review 8.  Anal cancer: are we making progress?

Authors:  Ajay Aggarwal; Simon Duke; Rob Glynne-Jones
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

Review 9.  Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature.

Authors:  K Fakhrian; T Sauer; A Dinkel; S Klemm; T Schuster; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2013-05-02       Impact factor: 3.621

10.  Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma.

Authors:  Sawyna Provencher; Christoph Oehler; Sophie Lavertu; Marjory Jolicoeur; Bernard Fortin; David Donath
Journal:  Radiat Oncol       Date:  2010-05-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.